405 related articles for article (PubMed ID: 21691075)
1. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
[TBL] [Abstract][Full Text] [Related]
2. The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling.
Lee J; Byun HJ; Lee MS; Jin YJ; Jeoung D; Kim YM; Lee H
Oncotarget; 2017 Jan; 8(1):1641-1654. PubMed ID: 27926483
[TBL] [Abstract][Full Text] [Related]
3. Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration.
Zhang XA; He B; Zhou B; Liu L
J Biol Chem; 2003 Jul; 278(29):27319-28. PubMed ID: 12738793
[TBL] [Abstract][Full Text] [Related]
4. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
[TBL] [Abstract][Full Text] [Related]
5. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
6. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
7. Tetraspanin CD82 inhibits protrusion and retraction in cell movement by attenuating the plasma membrane-dependent actin organization.
Liu WM; Zhang F; Moshiach S; Zhou B; Huang C; Srinivasan K; Khurana S; Zheng Y; Lahti JM; Zhang XA
PLoS One; 2012; 7(12):e51797. PubMed ID: 23251627
[TBL] [Abstract][Full Text] [Related]
8. Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway.
Jee B; Jin K; Hahn JH; Song HG; Lee H
Exp Mol Med; 2003 Feb; 35(1):30-7. PubMed ID: 12642901
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
10. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
11. KAI1/CD82, a tumor metastasis suppressor.
Liu WM; Zhang XA
Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis.
Bari R; Zhang YH; Zhang F; Wang NX; Stipp CS; Zheng JJ; Zhang XA
Am J Pathol; 2009 Feb; 174(2):647-60. PubMed ID: 19116362
[TBL] [Abstract][Full Text] [Related]
13. Regulation of urokinase receptor proteolytic function by the tetraspanin CD82.
Bass R; Werner F; Odintsova E; Sugiura T; Berditchevski F; Ellis V
J Biol Chem; 2005 Apr; 280(15):14811-8. PubMed ID: 15677461
[TBL] [Abstract][Full Text] [Related]
14. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.
Shinohara T; Miki T; Nishimura N; Nokihara H; Hamada H; Mukaida N; Sone S
Cancer Res; 2001 Jan; 61(2):673-8. PubMed ID: 11212267
[TBL] [Abstract][Full Text] [Related]
16. The peptide mimicking small extracellular loop domain of CD82 inhibits tumor cell migration, adhesion and induces apoptosis by inhibiting integrin mediated signaling.
Luan M; He X; Huang X; Zhang Q; Ma K
Biochem Biophys Res Commun; 2018 Sep; 503(4):2206-2211. PubMed ID: 29953857
[TBL] [Abstract][Full Text] [Related]
17. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
Choi UJ; Jee BK; Lim Y; Lee KH
Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
[TBL] [Abstract][Full Text] [Related]
18. Tetraspanin CD82 represses Sp1-mediated Snail expression and the resultant E-cadherin expression interrupts nuclear signaling of β-catenin by increasing its membrane localization.
Lee MS; Byun HJ; Lee J; Jeoung DI; Kim YM; Lee H
Cell Signal; 2018 Dec; 52():83-94. PubMed ID: 30189244
[TBL] [Abstract][Full Text] [Related]
19. Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion.
He B; Liu L; Cook GA; Grgurevich S; Jennings LK; Zhang XA
J Biol Chem; 2005 Feb; 280(5):3346-54. PubMed ID: 15557282
[TBL] [Abstract][Full Text] [Related]
20. A Novel Function of CD82/KAI1 in Sialyl Lewis Antigen-Mediated Adhesion of Cancer Cells: Evidence for an Anti-Metastasis Effect by Down-Regulation of Sialyl Lewis Antigens.
Yoshihama N; Yamaguchi K; Chigita S; Mine M; Abe M; Ishii K; Kobayashi Y; Akimoto N; Mori Y; Sugiura T
PLoS One; 2015; 10(4):e0124743. PubMed ID: 25923697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]